Evidence for a compromised dorsolateral prefrontal cortical parallel circuit in schizophrenia

Brain Research Reviews

Volumn 31, Issue 2-3, 2000, Pages 138-146

  Bunney, William E ^a   Bunney, Blynn G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Dorsolateral prefrontal cortex; Neurodevelopmental disorder; Schizophrenia

Indexed keywords

4 AMINOBUTYRIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROTRANSMITTER;

ANATOMY; AUTOPSY; BRAIN BLOOD FLOW; BRAIN DEVELOPMENT; BRAIN METABOLISM; BRAIN REGION; CELL MIGRATION; COGNITIVE DEFECT; CONFERENCE PAPER; HEREDITY; HUMAN; NERVE CELL NETWORK; NEUROPATHOLOGY; NEUROTRANSMISSION; PATHOPHYSIOLOGY; PREFRONTAL CORTEX; PRIORITY JOURNAL; SCHIZOPHRENIA; THALAMOCORTICAL TRACT; THALAMUS DORSOMEDIAL NUCLEUS;

ANIMALS; CEREBROVASCULAR CIRCULATION; HUMANS; PREFRONTAL CORTEX; SCHIZOPHRENIA;

EID: 0034053573     PISSN: 01650173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0173(99)00031-4     Document Type: Conference Paper

References (80)

1. Weinberger D.R., Lipska B.K. Cortical maldevelopment, antipsychotic drugs and schizophrenia: a search for common ground. Schizophr. Res. 16:1995;87-110.
2. Berman K.F., Torrey E.F., Daniel D.G., Weinberger D.R. Regional cerebral blood flow in monozygotic twins discordant and concordant for schizophrenia. Arch. Gen. Psychiatry. 49:1992;927-934.
3. Fleming K., Goldberg T.E., Binks S., Randolph C., Gold J.M., Weinberger D.R. Visuospatial working memory in patients with schizophrenia. Biol. Psychiatry. 41:1997;43-49.
4. Gold J.M., Carpenter C., Randolph C., Goldberg T.E., Weinberger D.R. Auditory working memory and Wisconsin Card Sorting Test performance in schizophrenia. Arch. Gen. Psychiatry. 54:1997;159-165.
5. Goldman-Rakic P.S., Selemon L.D. Functional and anatomical aspects of prefrontal pathology in schizophrenia. Schizophr. Bull. 23:1997;437-458.
6. Catafau A.M., Parellada E., Lomeana F.J., Bernardo M., Pavaia J., Ros D., Setoain J., Gonzalez-Monclaus E. Prefrontal and temporal blood flow in schizophrenia: resting and activation technetium-99m-HMPAO SPECT patterns in young neuroleptic-naïve patients with acute disease. J. Nuclear Med. 35:1994;935-941.
7. Ragland J.D., Gur R.C., Glahn D.C., Censits D.M., Smith R.J., Lazareth M.G., Alavi A., Gur R.E. Frontotemporal cerebral blood flow change during executive and declarative memory tasks in schizophrenia: a positron emission tomography study. Neuropsychology. 12:1998;399-413.
8. Fletcher P.C., McKenna P.J., Frith C.D., Grasby P.M., Friston K.J., Dolan R.J. Brain activations in schizophrenia during a graded memory task studied with functional neuroimaging. Arch. Gen. Psychiatry. 55:1998;1001-1008.
9. Carter C.S., Perlstein W., Ganguli R., Brar J., Mintun M., Cohen J.D. Functional hypofrontality and working memory dysfunction in schizophrenia. Am. J. Psychiatry. 155:1998;1285-1287.
10. Callicott J.H., Ramsey N.F., Tallent K., Bertolino A., Knable M.B., Coppola R., Goldberg T., van Gelderen P., Mattay V.S., Frank J.A., Moonen C.T., Weinberger D.R. Functional magnetic resonance imaging brain mapping in psychiatry: methodological issues illustrated in a study of working memory in schizophrenia. Neuropsychopharmacology. 18:1998;186-196.
11. Curtis V.A., Bullmore E.T., Brammer M.J., Wright I.C., Williams S.C., Morris R.G., Sharma T.S., Murray R.M., McGuire P.K. Attenuated frontal activation during a verbal fluency task in patients with schizophrenia. Am. J. Psychiatry. 155:1998;1056-1063.
12. Spence C.A., Hirsch S.R., Brooks D.J., Grasby P.M. Prefrontal cortex activity in people with schizophrenia and control subjects. Evidence from positron emission tomography for remission of 'hypofrontality' with recovery from acute schizophrenia. Brit. J. Psychiatry. 172:1998;316-323.
13. Buchsbaum M.S. Positron emission tomography studies of abnormal glucose metabolism in schizophrenic illness. Clin. Neurosci. 3:1995;122-130.
14. Taylor S.F. Cerebral blood flow activation and functional lesions in schizophrenia. Schiz. Res. 19:1996;129-140.
15. Weinberger D.R., Berman K.F., Zec R.F. Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia, I: Regional cerebral blood flow evidence. Arch. Gen. Psychiatry. 43:1986;114-124.
16. Kawasaki Y., Maeda Y., Urata K., Higashima T., Ide Y. A quantitative magnetic resonance imaging study of patients with schizophrenia. Eur. Arch. Gen. Psychiatry Clin. Neurosci. 242:1993;268-272.
17. Berman K.F., Torrey E.F., Daniel D.G., Weinberger D.R. Regional cerebral blood flow in monozygotic twins discordant and concordant for schizophrenia. Arch. Gen. Psychiatry. 49:1992;927-934.
18. Volz H.P., Gaser C., Heager F., Rzanny R., Mentzel H.J., Kreitschmann-Andermahr I., Kaiser W.A., Sauer H. Brain activation during cognitive stimulation with the Wisconsin Card Sort Test - a functional MRI study on healthy volunteers and schizophrenia. Psychiatry Res. 75:1997;145-157.
19. 31Phosphorus magnetic resonance spectroscopy of the dorsolateral prefrontal region in schizophrenics - a study including 50 patients and 36 controls Biol. Psych. 44:1998;399-404.
20. Bertolino A., Kumra S., Callicott J.H., Mattay V.S., Lestz R.M., Jacobsen L., Barnett I.S., Duyn J.H., Frank J.A., Rapoport J.L., Weinberger D.R. Common pattern of cortical pathology in childhood-onset and adult-onset schizophrenia as identified by proton magnetic resonance spectroscopic imaging. Am. J. Psychiatry. 155:1998;1376-1383.
21. Buchsbaum M.S., Haier R.J., Potkin S.G., Nuerchterlein K., Bracha H.S., Katz M., Lohr J., Wu J., Lottenberg S., Jerabek P.et al. Frontostriatal disorder of cerebral metabolism in never-medicated schizophrenics. Arch. Gen. Psychiatry. 49:1992;935-942.
22. Parellada E., Catafau A.M., Bernardo M., Lomeana F., Gonzaalez-Monclaus E., Setoain J. Prefrontal dysfunction in young acute neuroleptic-naïve schizophrenic patients: a resting and activation SPECT study. Psychiatry Res. 55:1994;131-139.
23. Andreasen N.C., O'Leary D.S., Flaum M., Nopoulos P., Watkins G.L., Boles Ponto L.L., Hichwa R.D. Hypofrontality in schizophrenia: distributed dysfunctional circuits in neuroleptic naïve patients. Lancet. 349:1997;1730-1734.
24. Erkwoh R., Sabri O., Steinmeyer E.M., Buell U., Sass H. Psychopathological and SPECT findings in never-treated schizophrenia. Acta Psychiatrica Scand. 96:1997;51-57.
25. Biver F., Goldman S., Luxen A., Delvenne V., DeMaertelaer V., De La Fuente J., Mendlewicz J., Lotstra F. Altered frontostriatal relationship in unmedicated schizophrenic patients. Psychiatry Res. 61:1995;161-171.
26. Jacobsen L.K., Hamburger S.D., van Horn J.D., Vaituzis A.C., McKenna K., Frazier J.A., Gordon C.T., Lenane M.C., Rapoport J.L., Zametkin A.J. Cerebral glucose metabolism in childhood onset schizophrenia. Psychiatry Res. 75:1997;131-144.
27. Hinsberger A.D., Williamson P.C., Carr T.J., Stanley J.A., Drost D.J., Densmore M.M., MacFabe G.C., Montemurro D.G. Magnetic resonance imaging volumetric and phosphorus 31 magnetic resonance spectroscopy measurements in schizophrenia. J. Psychiatry Neurosci. 22:1997;111-117.
28. Bertolino A., Callicott J.H., Elman I., Mattay V.S., Tedeschi G., Frank J.A., Breier A., Weinberger D.R. Regionally specific neuronal pathology in untreated patients with schizophrenia: a proton magnetic resonance spectroscope imaging study. Biol. Psychiatry. 43:1998;641-648.
29. Daviss S.R., Lewis D.A. Local circuit neurons of the prefrontal cortex in schizophrenia selective increase in the density of calbindin-immunoreactive neurons. Psychiatry Res. 59:1995;81-96.
30. Schlaepfer T.E., Harris G.J., Tien A.Y., Peng L.W., Lee S., Federman E.B., Chase G.A., Barta P.E., Pearlson G.D. Decreased regional cortical gray matter volume in schizophrenia. Am. J. Psychiatry. 151:1994;842-848.
31. Sullivan E.V., Mathalon D.H., Lim K.O., Marsh L., Pfefferbaum A. Patterns of regional cortical dysmorphology distinguishing schizophrenia and chronic alcoholism. Biol. Psychiatry. 43:1998;118-131.
32. Buchanan R.W., Vladat K., Barta P.E., Pearlson G.D. Structural evaluation of the prefrontal cortex in schizophrenia. Am. J. Psychiatry. 155:1998;1049-1055.
33. Ohnuma T., Kimura M., Takahashi T., Iwamoto N., Arai H. A magnetic resonance imaging study in first-episode disorganized-type patients with schizophrenia. Psychiatry Clin. Neurosci. 52:1997;9-15.
34. Bilder R.M., Wu H., Bogerts B., Degreef G., Ashtari M., Alvir J.M., Snyder P.J., Lieberman J.A. Absence of regional hemispheric volume asymmetries in first-episode schizophrenia. Am. J. Psychiatry. 151:1994;1437-1447.
35. Wible C.G., Shenton M.E., Fischer I.A., Allard J.E., Kikinis R., Jolesz F.A., Iosifescu D.V., McCarley R.W. Parcellation of the human prefrontal cortex using MRI. Psychiatry Res. 76:1997;29-41.
36. Buchsbaum M.S., Tang C.Y., Peled S., Gudbjartsson H., Lu D., Hazlett E.A., Downhill J., Haznedar M., Fallon J., Atlas S.W. MRI white matter diffusion anisotropy and PET metabolic rate in schizophrenia. Neuroreport. 9:1998;425-430.
37. Mednick S.A., Huttunen M.O., Machon R.A. Prenatal influenza infections and adult schizophrenia. Schizophr. Bull. 20:1994;263-267.
38. Mednick S.A., Machon R.A., Huttunen M.O. Adult schizophrenia following prenatal exposure to an influenza epidemic. Arch. Gen. Psychiatry. 45:1988;189-192.
39. Morgan V., Castle D., Page A., Fazio S., Gurrin L., Burton P., Montgomery P., Jablensky A. Influenza epidemics and incidence of schizophrenia, affective disorders and mental retardation in Western Australia: no evidence of a major effect. Schizophr. Res. 26:1997;25-39.
40. Selten J.P., Slaets J., Kahn R. Prenatal exposure to influenza and schizophrenia in Surinamese and Dutch Antillean immigrants to The Netherlands. Schizophr. Res. 30:1998;101-103.
41. Huttunen M.O., Niskana P. Prenatal loss of father and psychiatric disorders. Arch. Gen. Psychiatry. 35:1978;429-431.
42. Van Os J., Selten J.P. Prenatal exposure to maternal stress and subsequent schizophrenia. The May 1940 invasion of The Netherlands. Brit. J. Psychiatry. 172:1998;324-326.
43. Susser E., Neugebauer R., Hoek H., Lin S., Labovitz D., Gorman J. Schizophrenia after prenatal famine: further evidence. Arch. Gen. Psychiatry. 53:1996;25-31.
44. Benes F.M., Vincent S.L., Marie A., Khan Y. Up-regulation of GABA-A receptor binding on neurons of the prefrontal cortex in schizophrenic subjects. Neuroscience. 75(4):1996;1021-1031.
45. Benes F.M., Vincent S.L., Alsterberg G., Bird E.D., Giovanni J.P. Increased GABAA receptor binding in superficial layers of cingulate cortex in schizophrenics. J. Neurosci. 12:1992;924-929.
46. Benes F.M., McSparren J., Bird E.D., SanGiovanni J.P., Vincent S.L. Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients. Arch. Gen. Psychiatry. 48:1991;996-1001.
47. Rajkowska G., Selemon L.D., Goldman-Rakic P.S. Neuronal and glial somal size in the prefrontal cortex: a postmortem morphometric study of schizophrenia and Huntington disease. Arch. Gen. Psychiatry. 55:1998;215-224.
48. Benson D.L., Huntsman M.M., Jones E.G. Activity-dependent changes in GAD and preprotachykinin mRNAs in visual cortex of adult monkeys. Cereb. Cortex. 4:1994;40-51.
49. Selemon L.D., Rajkowska G., Goldman-Rakic P.S. Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17. Arch. Gen. Psychiatry. 52:1995;805-818.
50. Selemon L.D., Rajkowska G., Goldman-Rakic P.S. Elevated neuronal density in prefrontal area 46 in brains from schizophrenic patients: application of a three-dimensional, stereologic counting method. J. Comp. Neurol. 392:1998;402-412.
51. Alexander G.E., DeLong M.R., Strick P.L. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Ann. Rev. Neurosci. 9:1986;357-381.
52. Popken G.J., Bunney W.E., Potkin S.G., Jones E.G. Neuron number and GABA-ergic and glutamatergic mRNA expression in subdivisions of the thalamic mediodorsal nucleus of schizophrenics. Soc. Neurosci. 24:1998;991.
53. Pakkenberg B. Pronounced reduction of total neuron number in mediodorsal thalamic nucleus and nucleus accumbens in schizophrenics. Arch. Gen. Psychiatry. 47:1990;1023-1028.
54. Pakkenberg B. The volume of the mediodorsal thalamic nucleus in treated and untreated schizophrenics. Schizophr. Res. 7:1992;95-100.
55. Pakkenberg B. Leucotomized schizophrenics lose neurons in the mediodorsal thalamic nucleus. Neuropathol. Appl. Neurobiol. 19:1993;373-380.
56. Omori M., Pearce J., Komoroski R.A., Griffin W.S., Mrak R.E., Husain M.M., Karson C.N. In vitro 1H-magnetic resonance spectroscopy of postmortem brains with schizophrenia. Biol. Psychiatry. 42:1997;359-366.
57. Portas C.M., Goldstein J.M., Shenton M.E., Hokama H.H., Wible C.G., Fischer I., Kikinis R., Donnino R., Jolesz F.A., McCarley R.W. Volumetric evaluation of the thalamus in schizophrenic male patients using magnetic resonance imaging. Biol. Psychiatry. 43:1998;649-659.
58. Wolkin A., Rusinek H., Vaid G., Arena L., Lafargue T., Sanfilipo M., Loneragan C., Lautin A., Rotrosen J. Structural magnetic resonance image averaging in schizophrenia. Am. J. Psychiatry. 155:1998;1064-1073.
59. Kostovic I., Rakic P. Cytology and time of origin of interstitial neurons in the white matter in infant and adult human and monkey telencephalon. J. Neurocytol. 9:1980;219-242.
60. Allendoerfer K.L., Shatz C.J. The subplate, a transient neocortical structure: its role on the development of connections between thalamus and cortex. Ann. Rev. Neurosci. 9:1986;357-381.
61. Bredt D.S., Glatt C.E., Hwang P.M., Fotuhi M., Dawson T.M., Snyder S.H. Nitric oxide synthase protein and mRNA are discretely localized in neuronal populations of the mammalian CNS together with NADPH diaphorase. Neuron. 7:1991;2811-2814.
62. Akbarian S., Bunney W.E. Jr., Potkin S.G., Wigal S.B., Hagman J.O., Sandman C.A., Jones E.G. Altered distribution of nicotinamide-adenine-dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development. Arch. Gen. Psychiatry. 50:1993;169-177.
63. Akbarian S., Vinuela A., Kim J.J., Potkin S.G., Bunney W.E. Jr., Jones E.G. Distorted distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase neurons in temporal lobe of schizophrenics implies anomalous cortical development. Arch. Gen. Psychiatry. 50:1993;178-187.
64. Akbarian S., Kim J.J., Potkin S.G., Hetrick W.P., Bunney W.E. Jr., Jones E.G. Maldistribution of interstitial neurons in prefrontal white matter of schizophrenics. Arch. Gen. Psychiatry. 53:1996;178-187.
65. Anderson S.A., Volk D.W., Lewis D.A. Increased density of microtubule associated protein 2-immunoreactive neurons in the prefrontal white matter of schizophrenic subjects. Schizophr. Res. 19:1996;111-119.
66. Sherman A.D., Davidson A.T., Baruah S., Hegwood T.S., Waziri R. Evidence of glutamatergic deficiency in schizophrenia. Neurosci. Lett. 121:1991;77-80.
67. Simpson M.D., Slater P., Deakin J.F. Gamma-aminobutyric acid uptake binding sites in frontal and temporal lobes in schizophrenia. Biol. Psychiatry. 44:1998;423-427.
68. Reynolds G.P., Czudek C., Andrews H.B. Deficit and hemispheric asymmetry of GABA uptake sites in the hippocampus in schizophrenia. Biol. Psychiatry. 27:1990;1038-1044.
69. Woo T.U., Whitehead R.E., Melchitzky D.S., Lewis D.A. A subclass of prefrontal gamma-aminobutyric acid axon terminals are selectively altered in schizophrenia. Proc. Nat. Acad. Sci. USA. 95:1998;5341-5346.
70. Hendry S.H.C., Jones E.G. Reduction in number of immunostained GABAergic neurons in deprived-eye dominance columns of monkey area 17. Nature. 320:1986;750-753.
71. Hendry S.H.C., Jones E.G. Activity-dependent regulation of GABA expression in the visual cortex of adult monkeys. Neuron. 1:1988;701-712.
72. Akbarian S., Kim J.J., Potkin S.G., Hagman J.O., Tafazzoli A., Bunney W.E. Jr., Jones E.G. Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch. Gen. Psychiatry. 52:1995;258-266.
73. Volk D.W., Austin M.C., Lewis D.A. Decreased expression of GAD mRNA in a subpopulations of GABA neurons in the prefrontal cortex of schizophrenic subjects. Soc. Neurosci. Abstract. 24:1998;986.
74. B.G. Bunney, W.E. Bunney, A. Carlsson, Schizophrenia and glutamate, in: F.E. Bloom, D.J. Kupfer et al. (Eds.), Psychopharmacology: The Fourth Generation of Progress, Raven Press, New York, pp. 1205-1214.
75. A receptor subunit gene expression in human prefrontal cortex: Comparison of schizophrenics and controls. Cerebral Cortex. 5:1995;550-560.
76. Akbarian S., Sucher N.J., Bradley D., Tafazzoli A., Trinh D., Hetrick W.P., Potkin S.G., Sandman C.A., Bunney W.E. Jr., Jones E.G. Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics. J. Neurosci. 16:1996;19-30.
77. Monyer H., Burnashev N., Laurie D.J., Sakmann B., Seeburg P.H. Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron. 12:1994;529-540.
78. Kleinschmidt A., Bear M.F., Singer W. Blockade of NMDA receptors disrupts experience-dependent modifications in kitten striate cortex. Science. 238:1987;355-358.
79. Schlaggar B.L., Fox K., O'Leary D.D.M. Postsynpatic control of plasticity in developing somatosensory cortex. Nature. 364:1993;623-626.
80. Li Y., Erzurumulu R.S., Chen C., Jhaveri S., Tonegawa S. Whisker-related neuronal patterns fail to develop in the trigeminal brainstem nuclei of NMDAR1 knockout mice. Cell. 76:1994;427-437.